CeCors, Inc. (OTCMKTS:CEOS) is one of the notable stocks which is moving higher in today’s trading session on unusual volume. At the time of writing, the stock is up by about 5.50% to $0.0770 with more than 260K shares traded hands, compared to its average volume of 307K shares. In fact, the stock has been witnessing a gradual rise over the past with a jump of 17%.
The company is specializes in the development and commercialization of mycology-based entheogenic, adaptogenic, and nootropic ingredients and formulations. From functional to psychedelic PsyKey believes in the magic of mushrooms.
Moreover, the company is also working on the scientific development of patentable technologies pertaining to the composition, bioavailability, and targeted delivery of entheogenic-based therapeutics for the fast-evolving psychedelic market.
Recently, the company acquired Nutra-Rox LLC, specializing in products featuring functional carbonated crystal delivery technology. Nutra-Rox formulates and manufactures innovative consumer products utilizing this patent-pending delivery technology for nutraceuticals and bioactive ingredients.
Impressively, the company, through its wholly-owned subsidiary PsyKey Inc., won its first purchase order in the amount of $50,000 for its functional mushroom-infused coffee line, from the innovative marketing firm “Union Marketing.”
Importantly, the company has been aggressively working on expanding its business portfolio. The stock has a partnership with The Professional Gardner Co LTD. The PsyKey – Professional Gardener partnership will engage in the development and distribution of unique, innovative products for the fast-growing, commercial mushroom production industry, organic farming and home-based markets.
PsyKey Inc also has a definitive agreement to form an exclusive strategic partnership with MycoVita Canada Inc., which is expected to accelerate the growth and market share for both companies, in the fast-growing mycology-based markets.
Considering the latest buzz, CEOS could be an interesting stock to watch in 2022.
